NASDAQ · Key Statistics

MannKind Corporation (MNKD) P/E Ratio, ROE & Key Statistics

$4.07 NASDAQ: MNKD Market Cap $1.31B

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for MannKind Corporation (MNKD), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-17.66
P/B ratioShare price divided by book value per share.-35.74
P/S ratioMarket value divided by annual revenue.3.24
PEG ratioP/E divided by the earnings growth rate.0.17
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.250.55
EV / RevenueEnterprise value against annual revenue.4.19
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.-5.66%
Free cash flow yieldFree cash flow as a percentage of market value.-5.88%
Price / free cash flowMarket value divided by free cash flow.-17.00

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.76.05%
Operating marginRevenue left after operating costs.-3.19%
Net marginRevenue left after every cost, including tax and interest.-18.10%
Return on equityProfit as a percentage of shareholders’ equity.139.41%
Return on assetsProfit as a percentage of total assets.-10.35%
Return on capital employedOperating profit against the capital the business uses.-2.15%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.2.22
Quick ratioThe same, excluding inventory.1.77
Cash ratioCash alone against current liabilities.0.44
Debt to equityTotal borrowings against shareholders’ equity.-11.63
Debt to assetsTotal borrowings against total assets.0.60
Interest coverageHow many times operating profit covers the interest bill.-0.27

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.$0.02
Book value per shareShareholders’ equity divided by shares outstanding.−$0.12
Market capitalisationShare price times shares outstanding.$1.31B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.$1.73B
EmployeesReported headcount.403

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

MannKind Corporation (MNKD) statistics — frequently asked questions

What is MannKind Corporation's P/E ratio?

MannKind Corporation (MNKD) trades on a price-to-earnings ratio of -17.66. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is MannKind Corporation's return on equity?

MannKind Corporation (MNKD) reports a return on equity of 139.41%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does MannKind Corporation carry?

MannKind Corporation (MNKD) has a debt-to-equity ratio of -11.63, which compares total borrowings with shareholders' equity.

What is MannKind Corporation's profit margin?

MannKind Corporation (MNKD) keeps -18.10% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Biotechnology stocks

VRTX P/E 34.56REGN P/E 19.22MRNA ROE -37.62%RVMD ROE -91.93%ROIV ROE -6.12%INSM ROE -82.75%UTHR P/E 21.31INCY P/E 55.62ALNY P/E 36.02ASND P/E 17.60All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.